• SHOP
    • COMBOS
    • TESTIMONIALS
    • CART
    • INGREDIENTS
      • 2-DEOXY-D-GLUCOSE (2DG)
      • ACACIA CYANOPHYLLA FLOWER
      • ACORI GRAMINEI RHIZOMA
      • AEGLE MARMELOS CORREA
      • AGARICUS BLAZEI
      • AGED GARLIC EXTRACT
      • AFRAMOMUM MELEGUETA
      • ALOE ARBORESCENS
      • ALBIZIA
      • ALPINIA OFFICINARUM
      • ALTERNANTHERA SESSILIS
      • AMERICAN GINSENG
      • AMYGDALIN
      • ANACYCLUS PYRETHRUM
      • ANGELICA ARCHANGELICA
      • ANGELICA SINENSIS
      • ANTRODIA
      • ARTICHOKE LEAF
      • ARTOCARPIN
      • AJUGA TURKESTANICA
      • ASHWAGANDHA
      • ASPALATHIN
      • ASTRAGALUS COMPLANATUS
      • AVENA SATIVA
      • BACOPA MONNIERI
      • BAVACHIN
      • BEE POLLEN
      • BETULINIC ACID
      • BOSWELLIC ACID
      • BREVILIN A
      • CAMPESTEROL
      • CAPSAICIN
      • CARCININE
      • CASTICIN
      • CHRYSIN
      • CINNAMOMUM ZEYLANICUM
      • CITRULLUS COLOCYNTHIS
      • CITRUS RETICULATA PEEL
      • CODONOPSIS
      • CONJUGATED LINOLEIC ACID
      • COSTUNOLIDE
      • CUCURBITACIN D
      • DAIDZEIN
      • DECURSIN
      • DELPHINIDIN
      • DIGITALIS PURPREA (DIGOXIN)
      • DIOSMIN
      • EMBELIN
      • GALLIC ACID
      • GLYCITEIN
      • GLYCYRRHIZIN
      • HYPERFORIN
      • ICARIIN
      • ISORHAMNETIN
      • ISOORIENTIN
      • ISOVITEXIN
      • JACEOSIDIN
      • KAEMPFEROL
      • KIGELIA AFRICANA
      • KURARINONE
      • LEMON BALM
      • LICORICIDIN
      • LIPOIC ACID
      • LUPEOL
      • MAGNOLOL
      • MULBERRY LEAF
      • NARINGENIN
      • NOBILETIN
      • OLEACEIN
      • OLEANOLIC ACID
      • OLIVE OIL
      • ORIDONIN
      • PARTHENOLIDE
      • PHLOROGLUCINOL
      • PICEATANNOL
      • PRISTIMERIN
      • PROANTHOCYANIDINS
      • PROCYANIDIN B3
      • PSEUDOLARIC ACID B
      • PTEROSTILBENE
      • RUTIN
      • SOLIDAGO VIRGAUREA
      • TANGERETIN
      • TARAXASTEROL
      • TRICHOSTATIN A
      • WEDELOLACTONE
      • WOGONIN
      • YERBA MATE
    • ABOUT
    • SCIENTIFIC STUDIES
      • ALLERGIES & CYTOKINES
      • ALDOSTERONE & OBESITY/HYPERTENSION
      • ANTI-ACNE EFFECT OF FLAVONOIDS AND POLYPHENOLS
      • ADVANCED GLYCATION END PRODUCTS (AGES)
      • ADIPOCYTE APOPTOSIS (KILLING FAT CELLS)
      • ADIPOCYTE DEDIFFERENTIATION (THE REVERSAL OF FAT FORMATION)
      • AMPK
      • ANTI AGING
      • ANTI-AGING EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-APOPTOTIC PATHWAYS
      • ANTI-CANCER EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI COVID-19 EFFECTS OF MEDICINAL PLANTS, FLAVONOIDS & POLYPHENOLS
      • ANTI-INFLAMMATORY EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-VIRAL EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI WRINKLE AGENTS
      • APOPTOSIS
      • AUTOPHAGY
      • BCL-2
      • BCL-W
      • BCL-XL
      • BDNF
      • BECLIN-1 & AUTOPHAGY
      • BH3 MIMETICS
      • BIM aka BCL2L11
      • BMI-1
      • BRASSINOSTEROIDS
      • CARDIAC GLYCOSIDES
      • CELL CYCLE ARREST
      • CENTENARIANS
      • CRYOTHERAPY
      • CRYOLIPOLYSIS: FREEZING FAT TO DEATH
      • CYP2E1
      • CYTOKINES IN PAIN, INFLAMMATION & AGING
      • DAF-16
      • DIABETES & CANCER
      • DIHYDROTESTOSTERONE (DHT)
      • ELLAGITANNINS
      • EPIGENETIC MODIFIERS
      • ERGOGENIC AGENTS (INCREASE ATHLETIC PERFORMANCE)
      • EXCITOXICITY & THE BRAIN
      • FASTING & CANCER
      • FEAR EXTINCTION
      • FGF21
      • FLAVONES
      • GALLOTANNINS
      • GLUTAMATE & BRAIN
      • KLOTHO
      • FASTING, CALORIE RESTRICTION & EXTENDING LIFESPAN
      • FOXO3
      • FOXO4
      • HEPATOPROTECTIVE AGENTS (KEEPING LIVER HEALTHY)
      • HMGB1
      • HORMESIS
      • HSP90 INHIBITORS
      • HYPERINSULINEMIA
      • HYPOACTIVE SEXUAL DESIRE (WHY PEOPLE HAVE ZERO SEX DRIVE)
      • IKK
      • IL-6/STAT3
      • IRISIN
      • ISOFLAVONES
      • IMMUNOSENESCENCE
      • INFECTOBESITY
      • INFLAMMATION & ANXIETY
      • INFLAMMATION & CANCER
      • INFLAMMATION & DEPRESSION
      • INFLAMMATION & OBESITY
      • INFLAMMAGING
      • INSULIN & AGING
      • INSULIN & CANCER: HOW INSULIN LITERALLY PROTECTS CANCER CELLS FROM BEING KILLED
      • INSULIN & MTOR
      • INSULIN & OBESITY
      • INTERMITTENT FASTING
      • JAK INHIBITION ALLEVIATES SASP
      • JNK ACTIVATION PREVENTS PREMATURE SENESCENCE
      • KETONE BODIES
      • KETOGENIC DIET
      • LIFESPAN EXTENSION
      • LIPOLYSIS (THE DECOMPOSITION OF BODY FAT)
      • LOWERING CHOLESTEROL THRU FASTING, DIET & MEDICINAL PLANTS
      • MATRIX METALLOPROTEINASES (MMPs)
      • MCL-1
      • MITOCHONDRIAL UNCOUPLING
      • MDM2 INHIBITION AS SASP INHIBITOR
      • MSG (MONOSOSODIUM GLUTAMATE)
      • MYOSTATIN INHIBITION
      • MYOSTATIN INHIBITION PRESERVES MUSCLE
      • mTOR: THE RAPID AGING PATHWAY
      • NATURAL AROMATASE INHIBITORS
      • NEUROGENESIS (GROWING NEW BRAIN CELLS)
      • NEUROINFLAMMATION
      • NMDA & ANXIETY & DEPRESSION
      • NMDA RECEPTOR AND FEAR
      • NON-OPIOID ANALGESICS (PLANT BASED)
      • NOOTROPICS
      • NRF2: MASTER REGULATOR OF THE AGING PROCESS
      • NF-KB
      • ONCOGENE ACTIVATION INDUCED SENESCENCE
      • OXIDATIVE STRESS & AGING
      • P16INK4A
      • P38MAPK
      • P53: TUMOR SUPRESSOR
      • PHYTOSTEROLS
      • PHYTOSTANOLS
      • PHYTOECDYSTEROIDS
      • PROANTHOCYANIDINS
      • POLYAMINES & THEIR EFFECT ON BRAIN (NMDA, DEPRESSION, SUICIDE RISK)
      • PPARY2
      • PREMATURE SENESCENCE
      • PREVENTING SKIN AGING
      • PURGATIVES
      • RAPAMYCIN (MTOR INHIBITION)
      • RENAL (KIDNEY) PROTECTIVE AGENTS
      • RESTORE INSULIN SENSITIVITY
      • SASP & ADIPOSE TISSUE
      • SENESCENT CELLS, SASP & SENOLYTICS
      • SENESCENCE-BETA-GALACTOSIDASE (SA-β-gal or SABG)
      • SGLT2 INHIBITORS
      • SKELETAL MUSCLE HYPERTROPHY (THE SCIENCE OF BUILDING MUSCLE)
      • SKIN ELASTICITY
      • SKIN PHOTOAGING (Preventing & Repairing)
      • SIRT1 & LONGEVITY
      • SUGAR & AGING
      • STAT3
      • TELOMERE SHORTENING & PREMATURE AGING
      • TRAUMATIC BRAIN INJURY (HEALING)
    • HOME
    • FAQ
    • CONTACT
    • INTERSTELLAR 88/8: EXTREME WEIGHTLOSS PROTOCOL
    • The Ultimate Dry Fasting Resource
    0
    BMI-1
    January 24, 2020
    KETONE BODIES
    January 24, 2020
    1. … -activated protein kinase kinase kinase 3 (MEKK3) is required for lysophosphatidic acid (LPA)-mediated optimal i [kappa] B kinase [beta](IKK [beta])/nuclear factor …
    2. … -induced expression of iNOS and COX-2 in BV2 murine microglial cells: possible involvement of reactive oxygen species, p38 MAPK, and IKK/NF-κB signaling …
    3. … -insufficiency improves cardiac function in early-stages of myocardial infarction by protecting myocardium and increasing angiogenesis by promoting IKK …
    4. … ) stimulates matrix mentalloproteinase-9 (MMP-9) production in cultured human chorion trophoblast cells through TNF alpha receptor 1 signalling to IKK beta, ERK1/2 …
    5. … 8 acute infection of endothelial cells induces monocyte chemoattractant protein 1–dependent capillary-like structure formation: role of the IKK/NF-κB pathway
    6. … acid-induced iNOS gene expression in macrophages possibly through downregulation of toll-like receptor 2-mediated activation of Raf-MEK1/2-ERK1/2-IKK-NFκB
    7. … and chemosensitizes leukemic cells through inhibition of gene expression regulated by TNF-TNFR1-TRADD-TRAF2-NIK-TAK1-IKK pathway”[Biochem. Pharmacol …
    8. … and the beautiful: A small dibromotyrosine derivative from Pseudoceratina sp. sponge exhibits potent apoptotic effect through targeting IKK/NFκB signaling pathway
    9. … antagonist blocks histamine-induced proinflammatory cytokine production through inhibition of Ca2+-dependent protein kinase C, Raf/MEK/ERK and IKK/IκB/NF-κB …
    10. … as a target to increase apoptosis in primary mediastinal B-cell lymphoma (PMBL): Results of studies with rituximab (RTX), bortezomib (BTZ) and small molecule IKK …
    11. … attenuates TNF-α-induced iNOS expression in human endothelial cells: Involvement of Syk-mediated activation of PI3K-IKK-IκB signaling pathways
    12. … between apoptosis in primary mediastinal B-cell lymphoma (PMBL) and NF-\# 954; B Pathway Blockade: Bortezomib (BTZ), small molecule IKK inhibitor ML120B and …
    13. … cascade leading to apoptosis.) The anti-inflammatory phenolic curcumin from Curcuma species (turmeric)(Zingiberaceae) inhibits the IB kinase (IKK) and thus inhibits …
    14. … Conditioning and Ventilation held in Hanover for the first time: Air conditioning systems made in the Far East challenge traditional systems; IKK 2001-22. Internationale …
    15. … deacetylase inhibitors SAHA and NVP-LAQ824 is enhanced by interrupting NF-kappaB activation through a mechanism involving inhibition of IKK-mediated RelA/p65 …
    16. … disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced …
    17. … from the Chinese medicinal plant Caesalpinia sappan L., protects neurons from microglia-mediated inflammatory injuries via inhibition of IκB kinase (IKK)-NF-κB and …
    18. … growth factor-2 15-LOX, 15-lipoxygenase receptor tyrosine kinase LPS, lipopolysaccharide iGlu-R, inhibitory glutamate receptor LT, leukotriene IKK, inhibitor B kinase …
    19. … Impaired migration and proliferation of bone marrow-derived mesenchymal stem cells from patients with systemic lupus erythematosus were mediated by IKK-β
    20. … in this paper: ApoE, apolipoprotein E; BAE, bovine aortic endothelial; Coll, collagen; FG, fibrinogen; FN, fibronectin; IHC, immunohistochemistry; IKK, IκB kinase; LN …
    21. … Increases in Apoptosis in Primary Mediastinal B-Cell Lymphoma (PMBL) and NF-κB Pathway Blockade: Bortezomib (BTZ), Small Molecule IKK Inhibitor ML120B and …
    22. … inhibitor, suppresses growth and chemosensitizes leukemic cells through inhibition of gene expression regulated by TNF-TNFR1-TRADD-TRAF2-NIK-TAK1-IKK …
    23. … low-density lipoprotein-induced inflammation in human mesangial cells through upregulation of XBP1 and suppression of the IRE1α/IKK/NF‑κB pathway
    24. … mortality and district characteristics (IKK) of the TUeV Rheinland; Das Informationssystem ueber Krebsmortalitaet und Kreischarakteristika (IKK) des TUeV Rheinland
    25. … of Ethanolic Extract of Pericarps of Mangosteen (Garcinia mangostana Linn.) on WiDr Cells and Interaction Study of Alpha-mangosteen to IKK and VEGF Based on …
    26. … of LPS-induced NO and PGE2 production by asiatic acid via NF-κB inactivation in RAW 264.7 macrophages: possible involvement of the IKK and MAPK pathways
    27. … of the NF-κ B pathway by the leukemogenic TEL-Jak2 and TEL-Abl fusion proteins leads to the accumulation of antiapoptotic IAP proteins and involves IKK α
    28. … oxide level in tomato regulated by a mammalian IKK/NF-κB like signaling pathway? Is nitric oxide level in tomato regulated by a mammalian IKK/NFκB-like signaling …
    29. … Pathways Regulating Hepatic Apolipoprotein B100 Production: Roles of Mitogen-activated Protein Kinases (MAPKs) and Inhibitor of NFkappaB Kinase (IKK) …
    30. … pylori Induction in Gastric Mucosal Prostaglandin and Nitric Oxide Generation Is Dependent on MAPK/ERK-Mediated Activation of IKK-β and cPLA2 …
    31. … the DKV planner’s forum at the IKK 2000; Integration lufttechnischer Systemloesungen in die Gebaeudeautomation. Beitrag vom DKV-Planerforum waehrend der IKK …
    32. … the solution structure of IκB kinase (IKK) subunit γ and its interaction with kaposi sarcoma-associated herpes virus flice-interacting protein and IKK subunit β by EPR …
    33. 129. OVARIAN PHENOTYPE OF THE IKK CONDITIONAL KNOCKOUT MOUSE
    34. 147: Inhibitory kappa B kinase (IKK) inhibition attenuates infarct size in a murine model of myocardial ischemia-reperfusion
    35. 15‐Deoxy‐Δ12,14‐prostaglandin J2 inhibits IL‐1β‐induced IKK enzymatic activity and IκBα degradation in rat chondrocytes through a PPARγ‐independent pathway
    36. 20-HETE Activates Endothelial ACE via an IKK/NF-kB Dependent Pathway
    37. 20-SOLA, a Novel Water Soluble 20-HETE Antagonist, Reduces Blood Pressure Through Regulation of Vascular ACE Expression via an IKK Dependent Pathway
    38. 241 Tnf-α Induction of Infant Murine Brain Inflammation Via IKK/Nf Kappa B Signalling: A Potential Model for Paediatric Neuroinflammation
    39. 3, 5-Disubstituted-indole-7-carboxamides: The discovery of a novel series of potent, selective inhibitors of IKK-β
    40. 3D‐QSAR Studies on a Class of IKK‐2 Inhibitors with GALAHAD Used to Develop Molecular Alignment Models
    41. 3D‐QSAR Study of Pyridine Derivates as IKK‐2 Inhibitors
    42. 4-Hydroxyestradiol induces neoplastic transformation of human breast epithelial cells by activating IKK-NF-κB signaling: possible involvement of reactive oxygen …
    43. 5-(1H-Benzimidazol-1-yl)-3-alkoxy-2-thiophenecarbonitriles as potent, selective, inhibitors of IKK-ε kinase
    44. 57: Pivotal role of the IKK-related kinase IKK epsilon to modulate IL29 or type I IFN induction during hepatitis C virus infection
    45. A dominant function of IKK/NF-κB signaling in global lipopolysaccharide-induced gene expression
    46. A feedforward loop of NLRC5 (de) ubiquitination keeps IKK–NF-κB in check
    47. A key mediator, PTX3, of IKK/IκB/NF-κB exacerbates human umbilical vein endothelial cell injury and dysfunction
    48. A Kinase Upstream of IKK
    49. A negative feedback loop between miR‐200b and the nuclear factor‐κB pathway via IKBKB/IKK‐β in breast cancer cells
    50. A new role for IKK-α in hepatitis C virus-induced lipogenesis.
    51. A Novel IKK Inhibitor IMD-0560: Suppresses Chronic Remodeling after Myocardial Ischemia
    52. A Novel IKK Inhibitor Prevents Progression of Neointimal Formation After Arterial Injury in Mice
    53. A novel IKK inhibitor prevents progression of restenosis after arterial injury in mice
    54. A novel IKK inhibitor suppresses heart failure and chronic remodeling after myocardial ischemia via MMP alteration
    55. A novel role for IκB kinase (IKK) α and IKKβ in ERK-dependent up-regulation of MUC5AC mucin transcription by Streptococcus pneumoniae
    56. A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma …
    57. A novel, highly selective, tight binding IκB kinase-2 (IKK-2) inhibitor: a tool to correlate IKK-2 activity to the fate and functions of the components of the nuclear factor-κB …
    58. A positive feedback loop involving EGFR/Akt/mTORC1 and IKK/NF-κB regulates head and neck squamous cell carcinoma proliferation
    59. A recurrent deletion in the ubiquitously expressed NEMO (IKK-γ) gene accounts for the vast majority of incontinentia pigmenti mutations
    60. A selective IKK-2 inhibitor blocks NF-κB-dependent gene expression in interleukin-1β-stimulated synovial fibroblasts
    61. A selective novel low‐molecular‐weight inhibitor of IκB kinase‐β (IKK‐β) prevents pulmonary inflammation and shows broad anti‐inflammatory activity
    62. A Specific IKK Inhibitor Suppresses Experimental Autoimmune Myocarditis in Rats
    63. A TNF &alphaA-responsive kinase activity may play a key role in IKK activation.
    64. A Truncated Form of IKKa Is Responsible for Specific Nuclear IKK Activity in Colorectal Cancer
    65. A truncated form of IKKα is responsible for specific nuclear IKK activity in colorectal cancer
    66. A truncated form of IKKα is responsible for specific nuclear IKK activity in colorectal cancer
    67. A ubiquitin replacement strategy in human cells reveals distinct mechanisms of IKK activation by TNFα and IL-1β
    68. A20-binding inhibitor of nuclear factor-B (NF-B)-2 (ABIN-2) is an activator of inhibitor of NF-B (IB) kinase (IKK)-mediated NF-B transcriptional activity
    69. AB0601 Anti-arthritis effects of (E)-2, 4-bis (P-hydroxyphenyl)-2-butenal through inhibition of IKK-beta activity
    70. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKα subunit of IκB kinase
    71. Abstract A41: The ASK1/IKK signaling axis mediates crosstalk between inflammation and apoptosis
    72. Abstract B59: IKK-mediated phosphorylation of the androgen receptor: A mechanism to modulate AR-cofactor interaction
    73. Abstract B71: Chemosensitization to bleomycin conferred by a constitutive activation of IKK pathway in viral FLIP expressing cells
    74. Abstract LB-144: I-kappa-B kinase (IKK) ε expression in pancreatic ductal adenocarcinoma
    75. Abstract LB-206: A novel scaffold that targets the IKK complex
    76. Abstract P1-01-11: Nuclear immunohistochemical IKK-εexpression in flat epithelial atypia (FEA) of the breast: A predictor of ipsilateral ADH, in-situ or invasive …
    77. Abstract P5-05-10: EIA-Induced PP2A Expression Prevents β-Trcp Mediated FOXO3a Degradation and Enhances Chemosensitization by Inhibiting TAK1/IKK …
    78. Abstract# 1196: Pro-inflammatory cytokine RANKL promotes tumor metastasis through the RANK-IKK\# 945; pathway
    79. Abstract# 1486: E1A-induced PP2A expression prevents\# 946; TrCP-mediated FOXO3a degradation and enhances chemosensitization by inhibiting TAK1/IKK …
    80. Abstract# 1790: Different roles of IKK alpha and IKK beta on NF-kB pathway in mantle cell lymphoma and diffuse large B-cell ympoma
    81. Abstract# 441: TRAF2 phosphorylation at Ser-55 inhibits stress-induced cell death by promoting prolonged IKK activation
    82. Abstract# 4700: p65 activity and ZAP-70 status predict the sensitivity of chronic lymphocytic leukemia cells to the selective IKK inhibitor BMS-345541
    83. Abstract# 4958: Pro-inflammatory cytokine RANKL promotes tumor metastasis through the RANK-IKK\# 945; pathway
    84. Abstract# 5050: 4-Hydroxyestradiol induces anchorage-independent growth of human mammary epithelial cells through ROS-mediated activation of IKK
    85. Abstract# 5269: TRAF2 suppresses IKK activity and inhibits TNFa-induced cell death independent of NF-kB activation
    86. Abstract# 5271: PKC-iota associates and phosphorylates IKK-\# 945;/\# 946; in breast cancer cell
    87. Abstract# 5488: IKK inhibitor Bay 11-7082 induces necrotic cell death in pre-B ALL cells
    88. Abstract# 5672: The role of IKK\# 946;/TSC1 regulation in tumorigenesis and insulin resistance
    89. Accumulation of phosphorylated IκBα and activated IKK in nodes of Ranvier
    90. Acetylation of MEK2 and IκB kinase (IKK) activation loop residues by YopJ inhibits signaling
    91. Activation mechanisms of endothelial NF-κB, IKK, and MAP kinase by tert-butyl hydroperoxide
    92. Activation of a Subset of Genes by IFN-γ Requires IKKβ but Not Interferon-Dependent Activation of NF-κB
    93. Activation of G-protein-coupled estrogen receptor inhibits the migration of human nonsmall cell lung cancer cells via IKK-β/NF-κB signals
    94. Activation of IKK by thymosin α1 requires the TRAF6 signalling pathway
    95. Activation of IKK by TNFα requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO
    96. Activation of IKK/NF-κB provokes renal inflammatory responses in guanylyl cyclase/natriuretic peptide receptor-A gene-knockout mice
    97. Activation of nuclear factor κB through the IKK complex by the topoisomerase poisons SN38 and doxorubicin: a brake to apoptosis in HeLa human carcinoma cells
    98. Activation of PI3K/Akt/IKK-α/NF-κB signaling pathway is required for the apoptosis-evasion in human salivary adenoid cystic carcinoma: its inhibition by quercetin
    99. Activation of the canonical IKK complex by K63/M1-linked hybrid ubiquitin chains
    100. Activation of the IκBα kinase (IKK) complex by double-stranded RNA-binding defective and catalytic inactive mutants of the interferon-inducible protein kinase …
    101. Activation of the virus-induced IKK/NF-kB signaling axis is critical for the replication of HCMV in quiescent cells
    102. Activation of the virus‐induced IKK/NF‐κB signalling axis is critical for the replication of human cytomegalovirus in quiescent cells
    103. Active nuclear IKK correlates with metastatic risk in cutaneous squamous cell carcinoma
    104. Activity of bortezomib, a proteasome inhibitor, in breast cancer cells: Association with negative estrogen receptor and IKK/NF-κB expression
    105. Adenovirus mediated gene transfer of mutated IKK and IκBα reveal NF-κB dependent as well as independent pathway of HAS1 activation
    106. Adenovirus-mediated IKK β KA expression sensitizes prostate carcinoma cells to TRAIL-induced apoptosis
    107. Adiponectin blocks interleukin-18-mediated endothelial cell death via APPL1-dependent AMP-activated protein kinase (AMPK) activation and IKK/NF-κB/PTEN …
    108. Advances in targeting IKK and IKK-related kinases for cancer therapy
    109. Akt-dependent regulation of NF-κB is controlled by mTOR and Raptor in association with IKK
    110. Akt/IKK [alpha]/Vav1 Signaling in Endothelial Cell Survival and Angiogenesis
    111. Alpha-lipoic acid inhibits TNF-α induced NF-κB activation through blocking of MEKK1–MKK4–IKK signaling cascades
    112. Altered TAB1: IKK Interaction Promotes TGF-β-Mediated NF-κB Activation During Breast Cancer Progression
    113. Amelioration of Arthritis by Intraarticular Dominant Negative IKKβ Gene Therapy Using Adeno-Associated Virus Type 5
    114. Aminopyridinecarboxamide-based inhaled IKK-2 inhibitors for asthma and COPD: Structure–activity relationship
    115. An inhibitor of the protein kinases TBK1 and IKK-ɛ improves obesity-related metabolic dysfunctions in mice
    116. Angiogenin mediates immune modulation and antiinflammatory reaction attenuating protein kinase IKK-ε in human corneal fibroblast cells
    117. Annexin-1 interacts with NEMO and RIP1 to constitutively activate IKK complex and NF-κB: implication in breast cancer metastasis
    118. Anthrax lethal toxin enhances I kappa B kinase (IKK) activation and differentially regulates pro-inflammatory genes in human endothelium (135.3)
    119. Anti-inflammatory effects of IKK inhibitor XII, thymulin, and fat-soluble antioxidants in LPS-treated mice
    120. Anticancer agent CHS 828 suppresses nuclear factor‐κB activity in cancer cells through downregulation of IKK activity
    121. Apigenin potentiates the growth inhibitory effects by IKK-β-mediated NF-κB activation in pancreatic cancer cells
    122. Apigenin suppresses IKK activation and downstream signaling leading to prostate cancer inhibition.
    123. Apoptotic role of IKK in T-ALL therapeutic response
    124. Are the IKKs and IKK-related kinases TBK1 and IKK-ɛ similarly activated?
    125. Aspirin inhibits IKK-β-mediated prostate cancer cell invasion by targeting matrix metalloproteinase-9 and urokinase-type plasminogen activator
    126. Association of a Network of Interferon-Stimulated Genes with a Locus Encoding a Negative Regulator of Non-conventional IKK Kinases and IFNB1
    127. Association of the adaptor TANK with the IκB kinase (IKK) regulator NEMO connects IKK complexes with IKKε and TBK1 kinases
    128. Astragaloside IV facilitates glucose transport in C2C12 myotubes through the IRS1/AKT pathway and suppresses the palmitate-induced activation of the IKK …
    129. ATM is required for IκB kinase (IKK) activation in response to DNA double strand breaks
    130. ATM-and NEMO-dependent ELKS ubiquitination coordinates TAK1-mediated IKK activation in response to genotoxic stress
    131. ATM-dependent nuclear accumulation of IKK-α plays an important role in the regulation of p73-mediated apoptosis in response to cisplatin
    132. ATP alters IKK-2 inhibitor affinity for IKK2 enzyme and reveals non-equivalent inhibitor binding sites
    133. ATS Abstract: IKK-ß Is Required For Rhinovirus Induced IFN-ß, IFN-» And Pro-inflammatory Cytokine Production In Vitro And In Vivo
    134. Atypical forms of incontinentia pigmenti in male individuals result from mutations of a cytosine tract in exon 10 of NEMO (IKK-γ)
    135. Aurora and IKK kinases cooperatively interact to protect multiple myeloma cells from Apo2L/TRAIL
    136. Autophagy protects intestinal epithelial cells against deoxynivalenol toxicity by alleviating oxidative stress via IKK signaling pathway
    137. BAG3 is required for IKK α nuclear translocation and emergence of castration resistant prostate cancer
    138. Bcl3 phosphorylation by Akt, Erk2, and IKK is required for its transcriptional activity
    139. Benznidazole blocks NF-κB activation but not AP-1 through inhibition of IKK
    140. Benzoxathiolone LYR-64 inhibits NF-kB activation via IKK complexin LPS-stimuated macrophages RAW 264. 7
    141. Berberine suppresses in vitro migration and invasion of human SCC-4 tongue squamous cancer cells through the inhibitions of FAK, IKK, NF-κB, u-PA and MMP-2 and …
    142. Betafectin immunomodulator increases the activities of JNK and IKK kinases and increases the nuclear translocation of AP-1 in macrophage cells.
    143. BIOCHEMICAL CHARACTERIZATION OF SUPPRESSOR OF IKK-ε AND NAK-ASSOCIATED PROTEIN 1
    144. Biochemical Properties of IKK and Bcl3
    145. Bioinformatics Predictions of IKK Related Proteins Binding Long Non-Coding RNAs
    146. Biologic sequelae of IκB kinase (IKK) inhibition in multiple myeloma: therapeutic implications
    147. Biomechanical signals inhibit IKK activity to attenuate NF‐κB transcription activity in inflamed chondrocytes
    148. Bortezomib Increases IL-8 Expression in Ovarian Cancer Cells Through IKK and EGR-1 Pathways
    149. Brazilin selectively disrupts proximal IL-1 receptor signaling complex formation by targeting an IKK-upstream signaling components
    150. Breaking resistance of pancreatic cancer cells to an attenuated vesicular stomatitis virus through a novel activity of IKK inhibitor TPCA-1
    151. C-Terminal Serine Rich Region of IKK– Interacts with Bfl-1, a Homologue of Bcl-2
    152. C70 THE NEXT NEW THERAPEUTIC TARGET? TRANSLATIONAL STUDIES OF COPD THERAPIES: The Effect Of An Ikgr; b-Kinase-[Beta](IKK [Beta]) Inhibitor On …
    153. Ca2+/calmodulin-dependent protein phosphatase calcineurin mediates the expression of iNOS through IKK and NF-κB activity in LPS-stimulated mouse peritoneal …
    154. Caffeic acid regulates LPS-induced NF-κB activation through NIK/IKK and c-Src/ERK signaling pathways in endothelial cells
    155. Cardiomyocyte-specific IκB kinase (IKK)/NF-κB activation induces reversible inflammatory cardiomyopathy and heart failure
    156. Carnosic acid modulates Akt/IKK/NF-κB signaling by PP2A and induces intrinsic and extrinsic pathway mediated apoptosis in human prostate carcinoma PC-3 cells
    157. CD147 promotes IKK/IκB/NF-κB pathway to resist TNF-induced apoptosis in rheumatoid arthritis synovial fibroblasts
    158. CFC replacement in the focus of attention at the IKK’91 in Essen. IKK 91 in Essen im Zeichen der FCKW-Substitution
    159. Characterization of the bovine IκB kinases (IKK) α and IKKβ, the regulatory subunit NEMO and their substrate IκBα
    160. Characterization of the IKK Signaling Complex
    161. Characterization of the inhibitor of kappaB kinase (IKK) complex in granulosa cell tumors of the ovary and granulosa cell tumor-derived cell lines
    162. Chemosensitization in non‐small cell lung cancer cells by IKK inhibitor occurs via NF‐κB and mitochondrial cytochrome c cascade
    163. Chlamydia pneumoniae activates IKK/IκB-mediated signaling, which is inhibited by 4-HNE and following primary exposure
    164. Chronic alcohol exposure exacerbates inflammation and triggers pancreatic acinar-to-ductal metaplasia through PI3K/Akt/IKK
    165. cIAP2 negatively regulates proliferation and tumourigenesis by repressing IKK activity and maintaining p53 function
    166. Ciglitazone ameliorates lung inflammation by modulating the IKK/NF-κB pathway following hemorrhagic shock
    167. CIGLITAZONE REDUCES NF-κB ACTIVITY BY INHIBITING IKK IN HEMORRHAGIC SHOCK.: 58
    168. Cis-guggulsterone inhibits the IKK/NF-κB pathway, whereas trans-guggulsterone inhibits MAPK/AP-1 in MCF‑7 breast cancer cells: Guggulsterone regulates …
    169. CITED2 modulates metastatic ability through effects on IKK-alpha in breast cancer cells
    170. Classical NF-κB activation impairs skeletal muscle oxidative phenotype by reducing IKK-α expression
    171. Clinical study on the relationship between the activation of the IKK-IκB-NFκB pathway and insulin resistance
    172. Cloning and characterization of an IKK homologue from pearl oyster, Pinctada fucata
    173. Clostridium difficile toxin A promotes dendritic cell maturation and chemokine CXCL2 expression through p38, IKK, and the NF-κB signaling pathway
    174. Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-κB signal …
    175. Coincident enrichment of phosphorylated IκBα, activated IKK, and phosphorylated p65 in the axon initial segment of neurons
    176. Collagen and prostaglandin E2 regulate aromatase expression through the PI3K/AKT/IKK and the MAP kinase pathways in adipose stromal cells
    177. Combined use of pharmacokinetic modeling and a steady-state delivery approach allows early assessment of IκB kinase-2 (IKK-2) target safety and efficacy
    178. Complete Reconstitution of Human IκB Kinase (IKK) Complex in Yeast ASSESSMENT OF ITS STOICHIOMETRY AND THE ROLE OF IKKγ ON THE COMPLEX …
    179. Compound FLZ inhibits lipopolysaccharide-induced inflammatory effects via down-regulation of the TAK-IKK and TAK-JNK/p38MAPK pathways in RAW264. 7 …
    180. Comprehending the complex connection between PKCβ, TAK1, and IKK in BCR signaling
    181. Compressive mechanical stress may activate IKK-NF-κB through proinflammatory cytokines in MC3T3-E1 cells
    182. Conjugated linoleic acids produced by Lactobacillus dissociates IKK-γ and Hsp90 complex in Helicobacter pylori-infected gastric epithelial cells
    183. Connecting inflammation and cancer through the IKK-NF-κB nexus
    184. Constitutive Activation of NF-kappaB in Prostate Carcinoma Cells Through a Positive Feedback Loop: Implication of Inducible IKK-Related Kinase (IKKi)
    185. Constitutive Activation of NF-Kb in Prostate Carcinoma Cells through a Positive Feedback Loop: Implication of Inducible IKK-Related Kinase (IKKi)
    186. Constitutive activation of TAK1 by HTLV-1 tax-dependent overexpression of TAB2 induces activation of JNK-ATF2 but not IKK-NF-κB
    187. Constitutive and interleukin-1-inducible phosphorylation of p65 NF-κB at serine 536 is mediated by multiple protein kinases including IκB kinase (IKK)-α, IKKβ, IKKϵ …
    188. Context-dependent regulation of autophagy by IKK-NF-κB signaling: Impact on the aging process
    189. Control of canonical NF-κB activation through the NIK–IKK complex pathway
    190. Control of osteoclast activity and bone loss by IKK subunits: new targets for therapy
    191. Coordination of the canonical and noncanonical IKK/NF-κB signaling pathways in HTLV-I tax-mediated tumorigenesis
    192. Correlation between the signal pathway IKK/NF-? B and the anti-oxidant activity in asthma rats and the modulation of Ginkgo biloba extract
    193. Counter-regulation in the IKK family
    194. Crosstalk between the NF‐κB activating IKK‐complex and the CSN signalosome
    195. Crystal structure of a vFlip-IKKγ complex: insights into viral activation of the IKK signalosome
    196. Curcumin dually inhibits both mTOR and NF-κB pathways through a crossed PI3K/Akt/IKK signaling axis in adenoid cystic carcinoma
    197. Curcumin Treatment Suppresses IKK Kinase Activity of Salivary Cells of Patients with Head and Neck Cancer: A Pilot Study
    198. Cutting edge: the IκB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks inflammatory injury in murine colitis
    199. Cytokine receptor signaling activates an IKK-dependent phosphorylation of PUMA to prevent cell death
    200. Cytosolic Hsp60 is involved in the NF-κB-dependent survival of cancer cells via IKK regulation
    201. Cytotoxic Necrotizing Factor 1 Prevents Apoptosis via the AKT/IKK pathway: Role of NF-κB and Bcl-2
    202. Daphnetin inhibits TNF‐α and VEGF‐induced angiogenesis through inhibition of the IKK s/IκBα/NF‐κB, Src/FAK/ERK 1/2 and Akt signalling pathways
    203. Davallia bilabiata Inhibits TNF-α-Induced Adhesion Molecules and Chemokines by Suppressing IKK/NF-kappa B Pathway in Vascular Endothelial Cells
    204. Dbl and the Rho GTPases activate NFκB by IκB kinase (IKK)-dependent and IKK-independent pathways
    205. De-ubiquitylation is the most critical step in the ubiquitin-mediated homeostatic control of the NF-jB/IKK basal activity
    206. De-ubiquitylation is the most critical step in the ubiquitin-mediated homeostatic control of the NF-κB/IKK basal activity
    207. Deactivation of the kinase IKK by CUEDC2 through recruitment of the phosphatase PP1
    208. Decreased IKK Signaling in Skeletal Muscle of Patients with Hyperglycemic Crisis.
    209. Deficient natural killer cell cytotoxicity in patients with IKK-γ/NEMO mutations
    210. Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKK
    211. determine distinct IKK α Pleiotropic functions of TNF
    212. Dextran-g-lauric acid as IKK complex inhibitor carrier
    213. Differential IKK/NF-kB Activity Is Mediated by TSC2 through mTORC1 in PTEN-Null Prostate Cancer and Tuberous Sclerosis Complex Tumor Cells
    214. Differential IKK/NF-κB activity is mediated by TSC2 through mTORC1 in PTEN-null prostate cancer and tuberous sclerosis complex tumor cells
    215. Differential Requirement for the IKK
    216. Direct Phosphorylation of I kappa B by IKK [small alpha, Greek] and IKK [small beta, Greek]: Discrimination Between Free and NF-kappa B-Bound Substrate
    217. Direct, noncatalytic mechanism of IKK inhibition by A20
    218. Discovery of 6-Aryl-7-alkoxyisoquinoline Inhibitors of IκB Kinase-β (IKK-β)
    219. Discovery of 6-aryl-azabenzimidaoles that inhibit the TBK1/IKK-ε kinases
    220. Discovery of a novel IKK-β inhibitor by ligand-based virtual screening techniques
    221. Discovery of novel and selective IKK-β serine-threonine protein kinase inhibitors. Part 1
    222. DISCOVERY OF NOVEL IKK-Β INHIBITOR BY STRUCTURAL MODIFICATIONS OF CHLORPROPAMIDE AND NATEGLINIDE
    223. Discovery of novel potent nuclear factor kappa‐B inhibitors (IKK‐β) via extensive ligand‐based modeling and virtual screening
    224. Discovery of piperidinyl aminopyrimidine derivatives as IKK-2 inhibitors
    225. Disrupting the inhibitory Kappa B kinase (IKK)-Aurora A axis in cancer
    226. Disruption of IκB kinase (IKK)-mediated RelA serine 536 phosphorylation sensitizes human multiple myeloma cells to histone deacetylase (HDAC) inhibitors
    227. Distinct activation mechanisms of NF-κB regulator inhibitor of NF-κB kinase (IKK) by isoforms of the cell death regulator cellular FLICE-like inhibitory protein (cFLIP)
    228. Distinct B subunits of PP 2A regulate the NF‐κB signalling pathway through dephosphorylation of IKK β, IκBα and RelA
    229. Distinct roles for JNK and IKK activation in agouti-related peptide neurons in the development of obesity and insulin resistance
    230. Diversity oriented synthesis and IKK inhibition of aminobenzimidazole tethered quinazoline-2, 4-diones, thioxoquinazolin-4-ones, benzodiazepine-2, 3, 5-triones …
    231. DMA, a Bisbenzimidazole, Offers Radioprotection by Promoting NFκB Transactivation through NIK/IKK in Human Glioma Cells
    232. Docosahexaenoic acid inhibition of inflammation is partially via cross-talk between Nrf2/heme oxygenase 1 and IKK/NF-κB pathways
    233. Domain-specific interaction with the IκB kinase (IKK) regulatory subunit IKKγ is an essential step in Tax-mediated activation of IKK
    234. Drosophila IKK-related kinase Ik2 and Katanin p60-like 1 regulate dendrite pruning of sensory neuron during metamorphosis
    235. Drosophila IKK-related kinase regulates nonapoptotic function of caspases via degradation of IAPs
    236. Dynamic Characterization of the IKK: κBα: NFκB Negative Feedback Loop Using Real-Time Bioluminescence Imaging
    237. Dynamic interaction of stress granules, DDX3X, and IKK-α mediates multiple functions in hepatitis C virus infection
    238. E1A inhibition of radiation-induced NF-κB activity through suppression of IKK activity and IκB degradation, independent of Akt activation
    239. Effect and mechanism of IKK-2 receptor blocker on corneal stromal fibroblasts
    240. Effect and significance of anisodamine on I-kappaB kinase (IKK) in traumatic lung injury
    241. Effect of Collaterals-smoothing Drugs on Expressions of IκB-a and IKK-a in Sciatic Nerve of Diabetic Rats
    242. Effect of FK506 and Cyclosporin A on IκBα Degradation and IKK Pathway in Bronchial Epithelial Cells, Monocytes, Lymphocytes and Alveolar Macrophages
    243. Effect of IKK-2 Inhibitor on Local Th1 and Th2 Type Inflammation
    244. Effect of IKK-beta specific inhibitor PS1145 on NF-kappaB activity and apoptosis in prostate carcinoma cell lines
    245. Effect of Kuijieling decoction on proteins expression of IKK-alpha in colonic mucosa of ulcerative colitis model rats
    246. Effect of Rosiglitazone on Insulin Resistance and ROS. IKK Signaling Pathway in Vascular Endothelial Cells
    247. Effect of rosiglitazone on phosphorylation IKK and IκBα in the Heart of STZ Diabetic Rats [J]
    248. Effective suppression of pro‐inflammatory molecules by DHCA via IKK‐NF‐κB pathway, in vitro and in vivo
    249. Effects of a brief high-fat diet and acute exercise on the mTORC1 and IKK/NF-κB pathways in rat skeletal muscle
    250. Effects of IKK inhibitor PS1145 on NF-κ B function, proliferation, apoptosis and invasion activity in prostate carcinoma cells
    251. Effects of P-MAPA immunomodulator on Toll-like receptor 2, ROS, nitric oxide, MAPKp38 and IKK in PBMC and macrophages from dogs with visceral leishmaniasis
    252. Effects of Soothing Liver and Invigorating Spleen Recipes on the IKK-NF-B Signaling Pathway in Kupffer Cells of Nonalcoholic Steatohepatitis Rats
    253. Effects of TCDD upon IκB and IKK subunits localized in microsomes by proteomics
    254. El BUSINESS If IKK
    255. Embryonic lethality, liver degeneration, and impaired NF-κB activation in IKK-β-deficient mice
    256. EMMPRIN activates multiple transcription factors in cardiomyocytes, and induces interleukin-18 expression via Rac1-dependent PI3K/Akt/IKK/NF-κB andMKK7/JNK …
    257. Endothelial cell injury and dysfunction induced by silver nanoparticles through oxidative stress via IKK/NF-κB pathways
    258. Endothelial IKK β Signaling is Required for Monocyte Adhesion under Laminar Flow Conditions
    259. Endothelial-specific Deletion of Inhibitor of Kappa-B Kinase-β (IKK-β)
    260. Energy calibration of the IKK fast chopper with 238U standards
    261. Epithelial-cell-intrinsic IKK-β expression regulates intestinal immune homeostasis
    262. Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-κB pathway in carcinoma cells by inhibiting IKK phosphorylation
    263. Epstein–Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-κ B2 to p52 via an IKK γ/NEMO-independent signalling …
    264. ER stress activates NF-κB by integrating functions of basal IKK activity, IRE1 and PERK
    265. ERK is an anti-inflammatory signal that suppresses expression of NF-κB-dependent inflammatory genes by inhibiting IKK activity in endothelial cells
    266. Erratum to” Discovery of novel and selective IKK-b serine-threonine protein kinase inhibitors. Part 1″-(Bioorg. Med. Chem. Lett. 13 (2003) 913)
    267. Etanercept Reverses Downregulation of Inhibitor of Nuclear Factor Kappa-B Kinase Subunit Alpha (IKK [alpha]) in Psoriasis
    268. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-κ B activation and proliferation in human head and neck …
    269. Exclusion from the Golgi and very low levels of HTLV-2 Tax ubiquitination do not prevent IKK-gamma/NEMO relocalization and NF-B activation
    270. Exclusion from the Golgi and very low levels of HTLV-2 Tax ubiquitination do not prevent IKK-gamma/NEMO relocalization and NF-κB activation
    271. Exploring Suppressor of IKK Epsilon’s Interaction with Cytoskeletal Proteins
    272. Expression and function of NIK‐and IKK 2‐binding protein (NIBP) in mouse enteric nervous system
    273. Expression and regulation of inducible IκB kinase (IKK-i) in human fibroblast-like synoviocytes
    274. Expression, purification and functional characterization of IκB kinase-2 (IKK-2) mutants
    275. Faculty, IKK
    276. FAF1 suppresses IκB kinase (IKK) activation by disrupting the IKK complex assembly
    277. Falcarindiol impairs the expression of inducible nitric oxide synthase by abrogating the activation of IKK and JAK in rat primary astrocytes
    278. Fanconi anemia protein complex is a novel target of the IKK signalsome
    279. Feed-forward signaling of TNF-α and NF-κB via IKK-β pathway contributes to insulin resistance and coronary arteriolar dysfunction in type 2 diabetic mice
    280. Fentanyl Suppresses the Survival of CD4+ T Cells Isolated from Human Umbilical Cord Blood through Inhibition of IKKs‐mediated NF‐κB Activation
    281. fibrosis) at 28-days post reperfusion, which was markedly reduced by the late administration of IKK16. Conclusion: The late inhibition of IKK may, therefore, have …
    282. Flavokawain B, the hepatotoxic constituent from kava root, induces GSH-sensitive oxidative stress through modulation of IKK/NF-κB and MAPK signaling pathways
    283. Fluticasone reduces IL-6 and IL-8 production of cystic fibrosis bronchial epithelial cells via IKK-β kinase pathway
    284. FOXO 3 as a new IKK‐ε‐controlled check‐point of regulation of IFN‐β expression
    285. FoxO transcription factor is delocalized in CML patients by Bcr-Abl induced PI3K/AKT activation and IKK pathway and can be reactivated by Imatinib treatment
    286. FoxO Transcription Factor Is Delocalized in CML Patients by Bcr-Abl Induced PI3K/AKT Activation and IKK Pathway and Can Be Reactivated by Imatinib Treatment.
    287. Functional analysis of astroglial IKK/NF-KappaB signaling in brain development and homeostasis
    288. Functional Role of c-Src in IL-1–Induced NF-κB Activation: c-Src Is a Component of the IKK Complex
    289. GD2+ breast cancer stem cell growth is dependent on NFκB signaling and suppressed by the IKK inhibitor BMS345541 in vitro and in vivo
    290. Genistein sensitizes bladder cancer cells to HCPT treatment in vitro and in vivo via ATM/NF-κB/IKK pathway-induced apoptosis
    291. Ghrelin Suppression of Helicobacter pylori-Induced Gastric Mucosal Expression of iNOS is Mediated through the Inhibition of IKK-β Activation by cNOS …
    292. Gold compound auranofin inhibits IκB kinase (IKK) by modifying Cys-179 of IKKβ subunit
    293. GPx-1 Gene Delivery Modulates NFκB Activation Following Diverse Environmental Injuries Through a Specific Subunit of the IKK Complex
    294. GW26-e1432 Effect of Rosiglitazone on Insulin Resistance and ROS/IKK Signaling Pathway in Vascular Endothelial Cells
    295. GW26-e2212 Effect of Atorvastatin on IKK/NF-кB Pathway of Insulin Resistance in Vascular Endothelial Cells
    296. GW27-e0848 Effect of Celastrol on Insulin Resistance and ROS/IKK Signaling Pathway in Vascular Endothelial Cells
    297. H-RN, a novel antiangiogenic peptide derived from hepatocyte growth factor inhibits inflammation in vitro and in vivo through PI3K/AKT/IKK/NF-κB signal pathway
    298. hCINAP negatively regulates NF-κB signaling by recruiting the phosphatase PP1 to deactivate IKK complex
    299. HDAC/IKK inhibition therapies in solid tumors.
    300. Heat shock treatment suppresses angiotensin II-induced activation of NF-κB pathway and heart inflammation: a role for IKK depletion by heat shock?
    301. Hematopoietic progenitor kinase-1 (HPK1) stress response signaling pathway activates IκB kinases (IKK-α/β) and IKK-β is a developmentally regulated …
    302. Hepatic activation of IKK/NFκB signaling induces liver fibrosis via macrophage‐mediated chronic inflammation
    303. Hepatitis C virus infection activates an innate pathway involving IKK-α in lipogenesis and viral assembly
    304. Hepatocyte-specific IKK-β activation enhances VLDL-triglyceride production in APOE* 3-Leiden mice
    305. Hepatoprotective effect of quercetin against LPS/d-GalN induced acute liver injury in mice by inhibiting the IKK/NF-κB and MAPK signal pathways
    306. High glucose-induced IKK-Hsp-90 interaction contributes to endothelial dysfunction
    307. Hijacking of host cell IKK signalosomes by the transforming parasite Theileria
    308. Histone deacetylase (HDAC) inhibition induces IκB kinase (IKK)-dependent interleukin-8/CXCL8 expression in ovarian cancer cells
    309. Histone H3 phosphorylation by IKK-α is critical for cytokine-induced gene expression
    310. Hit Identification of IKK-beta Natural Product Inhibitor
    311. Hit-to-lead studies: the discovery of potent, orally active, thiophenecarboxamide IKK-2 inhibitors
    312. Honokiol ameliorates endothelial dysfunction through suppression of PTX3 expression, a key mediator of IKK/IκB/NF-κB, in atherosclerotic cell model
    313. Honokiol inhibits TNF-α-stimulated NF-κB activation and NF-κB-regulated gene expression through suppression of IKK activation
    314. Host and parasite-derived IKK activities direct distinct temporal phases of NF-κB activation and target gene expression following Toxoplasma gondii infection
    315. How NF-κB is activated: the role of the IκB kinase (IKK) complex
    316. HSP27 regulates IL-1 stimulated IKK activation through interacting with TRAF6 and affecting its ubiquitination
    317. Hsp90 inhibition results in autophagy-mediated proteasome-independent degradation of IκB kinase (IKK)
    318. HTLV-1 tax functions as a ubiquitin E3 ligase for direct IKK activation via synthesis of mixed-linkage polyubiquitin chains
    319. HTLV-1 tax induces formation of the active macromolecular IKK complex by generating Lys63-and Met1-linked hybrid polyubiquitin chains
    320. HTLV-1 Tax protein induces autophagy via IKK in human astroglioma cells: a protective mechanism against death receptor-mediated apoptosis (610.1)
    321. HTLV-1 Tax stimulates ubiquitin E3 ligase, ring finger protein 8, to assemble lysine 63-linked polyubiquitin chains for TAK1 and IKK activation
    322. Hyaluronan induces MMP-9 secretion through FAK-IKK/IκBα pathways and 17-AAG down-regulates these pathways in human glioma cells
    323. Hydrogen peroxide has opposing effects on IKK activity and I κ B α breakdown in airway epithelial cells
    324. Hyper activation of β‐catenin signalling induced by IKK ε inhibition thwarts colorectal cancer cell proliferation
    325. Hypothalamic programming of systemic ageing involving IKK-β, NF-κB and GnRH
    326. Hypoxia activates IKK–NF-κB and the immune response in Drosophila melanogaster
    327. I-kappa-kinase-2 (IKK-2) inhibition potentiates vincristine cytotoxicity in non-Hodgkin’s lymphoma
    328. Icariin attenuates lipopolysaccharide-induced microglial activation and resultant death of neurons by inhibiting TAK1/IKK/NF-κB and JNK/p38 MAPK pathways
    329. Identification of Human IKK-2 Inhibitors of Natural Origin (Part I): Modeling of the
    330. Identification of human IKK-2 inhibitors of natural origin (part I): modeling of the IKK-2 kinase domain, virtual screening and activity assays
    331. Identification of human IKK-2 inhibitors of natural origin (Part II): in Silico prediction of IKK-2 inhibitors in natural extracts with known anti-inflammatory activity
    332. Identification of mutations in TRAPPC9, which encodes the NIK-and IKK-β-binding protein, in nonsyndromic autosomal-recessive mental retardation
    333. IDENTIFICATION OF NOVEL SUBSTRATE I-TRAF OF IKK-i KINASE
    334. Identification of plumericin from Himatanthus Sucuuba as a novel potent inhibitor of the NF-κB pathway directly targeting IKK-β
    335. IFIT5 positively regulates NF-κB signaling through synergizing the recruitment of IκB kinase (IKK) to TGF-β-activated kinase 1 (TAK1)
    336. IKK Alfred, Crosby-house, 95, Bishopsgate-street
    337. IKK alpha coordinates with RAS to switch well-differentiated papillomas to poorly differentiated malignant carcinomas in skin
    338. IKK alpha induces angiogenesis
    339. IKK alpha play an inhibitory role in malignant skin tumor progression
    340. IKK and (Beta)-Catenin in Breast Cancer
    341. IKK and Caspases in Regulating Cell Shape
    342. IKK and Diabetic Nephropathy [J]
    343. IKK and NF‐κB‐mediated regulation of Claspin impacts on ATR checkpoint function
    344. IKK antagonizes activation-induced cell death of CD4+ T cells in aged mice via inhibition of JNK activation
    345. IKK antagonizes CD95 ligation-mediated apoptosis by regulating NF-κB activity
    346. IKK at the 580 revolutions the “down” run was made
    347. IKK biology
    348. IKK Capt. Gabriel J., 6, Belsize-park, Hampstead
    349. IKK Charles Henry, 51, King’s-road, Camden-town
    350. IKK connects autophagy to major stress pathways
    351. IKK cuts both ways in Huntington’s disease
    352. IKK Electric F40LW-RS-WMII at approximately 1000
    353. IKK epsilon Deficiency Exacerbates Inflammation in the Absence of an Interferon Response in Murine Arthritis by Delaying Neutrophil Apoptosis
    354. IKK epsilon kinase is crucial for viral G protein-coupled receptor tumorigenesis
    355. IKK epsilon, STAT1, and IFIT2 define a novel innate immune effector pathway against West Nile virus infection
    356. IKK exceptional, viz. the temperature high and the air
    357. IKK expression as an immunohistochemical marker for diagnosis of high risk flat epithelial atypia (FEA) of the breast
    358. IKK Goes BAD
    359. IKK have not saved, and to bury them when
    360. IKK Henry Charles, 86, South-hill-park, Hampstead
    361. IKK inhibition by BMS-345541 suppresses breast tumorigenesis and metastases by targeting GD2+ cancer stem cells
    362. IKK inhibition increases bortezomib effectiveness in ovarian cancer
    363. IKK inhibition prevents PM2. 5-exacerbated cardiac injury in mice with type 2 diabetes
    364. IKK inhibitor PS1145 increases sensitivity of pancreatic cancer cells to TRAIL-induced apoptosis.
    365. IKK inhibitor suppresses epithelial-mesenchymal transition and induces cell death in prostate cancer
    366. IKK inhibitory activities of imidazo [1, 2-a] pyrazine, imidazo [1, 2-a] quinoxaline, imidazo [1, 5-a] quinoxaline and pyrazolo [1, 5-a] quinoxaline derivatives.
    367. IKK interacts with rictor and regulates mTORC2
    368. IKK is a therapeutic target in KRAS-induced lung cancer with disrupted p53 activity
    369. IKK jar of the previous dayforgiven, if not for
    370. IKK kinase assay for assessment of canonical NF-κB activation in neurons
    371. IKK Links the Steroid Receptor Coactivator to Immune Responses
    372. IKK low much or how little it surprised
    373. IKK M.-What is memory aging the aging of? Developmental Psychology. 1978, 14
    374. IKK mediates ischemia-induced neuronal death
    375. IKK my passage-money is more than I can
    376. IKK NBD peptide inhibits LPS induced pulmonary inflammation and alters sphingolipid metabolism in a murine model
    377. IKK of ease, and little alle
    378. IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome
    379. IKK phosphorylates RelB to modulate its promoter specificity and promote fibroblast migration downstream of TNF receptors
    380. IKK phosphorylation of NF-κB at serine 536 contributes to acquired cisplatin resistance in head and neck squamous cell cancer
    381. IKK Phosphorylation, ICAM–1, and CD11a/LFA–1 Increases Are Correlated With VEGF–Induced Blood–Retinal Barrier Breakdown and Are Blocked by Triamcinolone …
    382. IKK Proverb,” that he who i
    383. IKK regulates the deubiquitinase CYLD at the postsynaptic density
    384. IKK regulation and human genetics
    385. IKK results are included AAAAA
    386. IKK SCienCe
    387. IKK Targets PI3K
    388. IKK that the fact was not suspected in his life
    389. IKK the night and the morrow in that disa
    390. IKK The North Central High School, Spökano
    391. IKK to British subjects, residing at Zan
    392. IKK to us, nor could it have influenced our
    393. IKK were entitled to protection against this system of
    394. IKK with ebonite is shown in the following
    395. IKK with Mr. E, Jones, Hibernian Schools, Liver.
    396. IKK yearly by government auditor, and pub
    397. IKK α represses a network of inflammation and proliferation pathways and elevates c-Myc antagonists and differentiation in a dose-dependent manner in the …
    398. IKK β in postnatal perichondrium remotely controls endochondral ossification of the growth plate through downregulation of MCP-5
    399. IKK β inhibitor identification: a multi-filter driven novel scaffold
    400. IKK β programs to turn on the GADD45α/MKK4/JNKs apoptotic cascade specifically via p50 NF-κB in arsenite response
    401. IKK β regulates endothelial thrombomodulin in a Klf2‐dependent manner
    402. IKK β-targeted anti-inflammatory activities of a butanol fraction of artificially cultivated Cordyceps pruinosa fruit bodies
    403. IKK-±: An Alternative Player In Inflammation-Induced Loss Of Muscle Oxidative Phenotype In COPD?
    404. IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation
    405. IKK-2
    406. IKK-2 inhibitor TPCA-1 represses nasal epithelial inflammation in vitro.
    407. IKK-2 is required for TNF-α-induced invasion and proliferation of human mesenchymal stem cells
    408. IKK-2/NF-κB-DEPENDENT TRANSCRIPTION
    409. IKK-alpha PROTEIN, NUCLEIC ACID ENCODING THE SAME AND METHOD
    410. IKK-and NF-κB-mediated functions in carcinogenesis
    411. IKK-Beta Deletion Alleviates the Atherogenetic Effect of Intermittent Hypoxia Induced Macrophage Foam Cell Formation
    412. IKK-dependent activation of NF-κB contributes to myeloid and lymphoid leukemogenesis by BCR-ABL1
    413. IKK-dependent, NF-κB-independent control of autophagic gene expression
    414. IKK-epsilon contributes to the malignant progression of ovarian cancer
    415. IKK-Epsilon, a novel factor identified by proteomics, contributes to prostate cancer cell-induced osteoclast activity in vitro.
    416. IKK-i and TBK-1 are Enzymatically Distinct from the Homologous Enzyme IKK-2 COMPARATIVE ANALYSIS OF RECOMBINANT HUMAN IKK-i, TBK-1, AND IKK-2
    417. IKK-i signals through IRF3 and NFκB to mediate the production of inflammatory cytokines
    418. IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IκB kinases
    419. IKK-i/IKKϵ controls constitutive, cancer cell-associated NF-κB activity via regulation of Ser-536 p65/RelA phosphorylation
    420. IKK-IKB-NF-kB gene manipulations and polymorphisms in relation to susceptibility to different diseases
    421. IKK-induced NF-κB1 p105 proteolysis is critical for B cell antibody responses to T cell–dependent antigen
    422. IKK-mediated signaling controls prostate tumor initiating cells
    423. IKK-NBD peptides exert anti-inflammation effect in rats after focal cerebral cortex ischemia/reperfusion via regulating c-rel [J]
    424. IKK-related genetic diseases: probing NF-κB functions in humans and other matters
    425. IKK-β inhibitors: An analysis of drug–receptor interaction by using Molecular Docking and Pharmacophore 3D-QSAR approaches
    426. IKK-β links inflammation to obesity-induced insulin resistance
    427. IKK-β mediates chemoresistance by sequestering FOXO3; a critical factor for cell survival and death
    428. IKK-β mediates hydrogen peroxide induced cell death through p85 S6K1
    429. IKK-β Recombinant Adenovirus
    430. IKK-β/NF-κB p65 mediates p27Kip1 protein degradation in arsenite response
    431. IKK-γ is an essential regulatory subunit of the IκB kinase complex
    432. IKK-γ, GST-tagged, human recombinant, expressed in Sf9 cells
    433. IKK